A Glucose‐Responsive Hydrogel Inhibits Primary and Secondary BRB Injury for Retinal Microenvironment Remodeling in Diabetic Retinopathy
Yue Zhou,Chan Zhao,Zhiyuan Shi,Zbynek Heger,HuaQing Jing,Zhengming Shi,Yunsheng Dou,Siyu Wang,Zitong Qiu,Nan Li
DOI: https://doi.org/10.1002/advs.202402368
IF: 15.1
2024-06-23
Advanced Science
Abstract:A glucose‐responsive hydrogel, Cu‐PEI/siMyD88@GEMA‐Con A (CSGC), is developed to deliver Cu‐PEI/siMyD88 NPs to the retinal pigment epithelium (RPE) (Figure a). Cu‐PEI acts as an antioxidant, reducing ROS and inhibiting RPE cells' pyroptosis, thus blocking primary blood‐retinal barrier (BRB) injury. Simultaneously, siMyD88 inhibits MyD88 expression, reducing IL‐18 and vascular endothelial growth factor (VEGF) expression, and enhancing tight junction protein expression, thus blocking secondary BRB injury (Figure b). In summary, the CSGC hydrogel efficiently remodels retinal microenvironment (RME), representing a promising diabetic retinopathy (DR) therapy. Current diabetic retinopathy (DR) treatment involves blood glucose regulation combined with laser photocoagulation or intravitreal injection of vascular endothelial growth factor (VEGF) antibodies. However, due to the complex pathogenesis and cross‐interference of multiple biochemical pathways, these interventions cannot block disease progression. Recognizing the critical role of the retinal microenvironment (RME) in DR, it is hypothesized that reshaping the RME by simultaneously inhibiting primary and secondary blood–retinal barrier (BRB) injury can attenuate DR. For this, a glucose‐responsive hydrogel named Cu‐PEI/siMyD88@GEMA‐Con A (CSGC) is developed that effectively delivers Cu‐PEI/siMyD88 nanoparticles (NPs) to the retinal pigment epithelium (RPE). The Cu‐PEI NPs act as antioxidant enzymes, scavenging ROS and inhibiting RPE pyroptosis, ultimately blocking primary BRB injury by reducing microglial activation and Th1 differentiation. Simultaneously, MyD88 expression silence in combination with the Cu‐PEI NPs decreases IL‐18 production, synergistically reduces VEGF levels, and enhances tight junction proteins expression, thus blocking secondary BRB injury. In summary, via remodeling the RME, the CSGC hydrogel has the potential to disrupt the detrimental cycle of cross‐interference between primary and secondary BRB injury, providing a promising therapeutic strategy for DR.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry